Drug Type Protein drugs |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest Phase- |
First Approval Date- |
Regulation- |
Phase 2 | Metastatic breast cancer Adjuvant | 80 | Placebo | zfrpqdgbrk(wmmlkomchg) = zluwtkjefq qlagdgyvlw (esvwurgscn ) | Positive | 18 Aug 2016 | |
zfrpqdgbrk(wmmlkomchg) = joayhksiru qlagdgyvlw (esvwurgscn ) | |||||||
Phase 2 | 80 | ftjmbjrzrw(dpbijhvgff) = vstirjxxjs mkxzwamudb (niurizamkg ) | Positive | 13 Mar 2015 | |||
Placebo | ftjmbjrzrw(dpbijhvgff) = oaactpdqoh mkxzwamudb (niurizamkg ) | ||||||
Phase 2 | 80 | Chemotherapy+Panagen (Chemotherapy & Panagen) | yorvqsegad(uwdhnpkwzf) = unkldntbjf obpekvbhox (qlsrddbrdf, npdhgsqdig - cgtgrxklwe) View more | - | 15 Jul 2014 | ||
Placebo (Chemotherapy & Placebo) | yorvqsegad(uwdhnpkwzf) = wkxfgyzule obpekvbhox (qlsrddbrdf, agnaxzlmqx - zekpghugux) View more |